The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
Open accessAbstract
We sought to examine mechanisms underlying nitroglycerin (NTG) tolerance and "cross-tolerance" to other nitrovasodilators. Rabbits were treated for 3 d with NTG patches (0.4 mg/h) and their aortic segments studied in organ chambers. Relaxations were examined after preconstriction with phenylephrine. In NTG tolerant rabbit aorta, relaxations to cGMP-dependent vasodilators such as NTG (45 +/- 6%), SIN-1 (69 +/- 7%), and acetylcholine (ACh, 64 +/- 5%) were attenuated vs. controls, (90 +/- 2, 94 +/- 3, and 89 +/- 2% respectively, P < 0.05 for all), while responses to the cAMP-dependent vasodilator forskolin remained unchanged. In tolerant aorta, endothelial removal markedly enhanced relaxations to NTG and SIN-1 (82 +/- 4 and 95 +/- 3%, respectively). Other studies were performed to determine how the endothelium enhances tolerance. Vascular steady state .-O2 levels (assessed by lucigenin chemiluminescence) was increased twofold in tolerant vs. control vessels with endothelium (0.31 +/- 0.01 vs. 0.61 +/- 0.01 nmol/mg per minute). This difference was less in vessels after denudation of the endothelium. Diphenylene iodonium, an inhibitor of flavoprotein containing oxidases, and Tiron a direct .-O2 scavenger normalized .-O2 levels. In contrast, oxypurinol (1 mM) an inhibitor of xanthine oxidase, rotenone (50 microM) an inhibitor of mitochondrial electron transport and NG-nitro-L-arginine (100 microM) an inhibitor of nitric oxide synthase did not affect the chemiluminescence signals from NTG-tolerant aortas. Pretreatment of tolerant aorta with liposome-entrapped, pH sensitive superoxide dismutase (600 U/ml) significantly enhanced maximal relaxation in response to NTG, SIN-1, and ACh, and effectively reduced chemiluminescence signals. These studies show that continuous NTG treatment is associated with increased vascular .-O2-production and consequent inhibition of NO. mediated vasorelaxation produced by both exogenous and endogenous nitrovasodilators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Self-citationMoore, P. K., Al‐Swayeh, O. A., Chong, N. W. S., Evans, R. A., & Gibson, A. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14717.x · Cited by 754
O'Donnell, V. B., Tew, D. G., Jones, O. T. G., & England, P. J. (1993) · Biochemical Journal · doi:10.1042/bj2900041 · Cited by 589
Cross, A. R., & Jones, O. T. G. (1986) · Biochemical Journal · doi:10.1042/bj2370111 · Cited by 551
NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
Mohazzab, K. M., Kaminski, P. M., & Wolin, M. S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2568 · Cited by 536
Superoxide radical and superoxide dismutase
Fridovich, I. (1972) · Accounts of Chemical Research · doi:10.1021/ar50058a001 · Cited by 469
Stuehr, D. J., Fasehun, O. A., Kwon, N. S., Gross, S. S., Gonzalez, J. A., Levi, R., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.1.1703974 · Cited by 464
The biochemical basis of the NADPH oxidase of phagocytes
Segal, A. W., & Abo, A. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90051-n · Cited by 459
Clark, R. A., Volpp, B. D., Leidal, K. G., & Nauseef, W. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114496 · Cited by 431
Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure
Packer, M., Lee, W. H., Kessler, P. D., Gottlieb, S. S., Medina, N., & Yushak, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171304 · Cited by 361
Lucigenin chemiluminescence in the assessment of neutrophil superoxide production
Gyllenhammar, H. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90461-3 · Cited by 356
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase
Elion, G. B., Kovensky, A., Hitchings, G. H., Metz, E., & Rundles, R. W. (1966) · Biochemical Pharmacology · doi:10.1016/0006-2952(66)90163-8 · Cited by 327
Understanding the controversy over the identity of EDRF
Feelisch, M., te Poel, M., Zamora, R., Deussen, A., & Moncada, S. (1994) · Nature · doi:10.1038/368062a0 · Cited by 242
Dupuis, J., Lalonde, G., Lemieux, R., & Rouleau, J. L. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80342-0 · Cited by 207
Chung, S. J., & Fung, H. L. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13024-3 · Cited by 181
Superoxide Radical and Superoxide Dismutases: Threat and Defense
Brawn, K., & Fridovich, I. (1980) · Autoxidation in Food and Biological Systems · doi:10.1007/978-1-4757-9351-2_24 · Cited by 177
Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.
Parker, J. D., Farrell, B., Fenton, T., Cohanim, M., & Parker, J. O. (1991) · Circulation · doi:10.1161/01.cir.84.6.2336 · Cited by 174
In Vivo Induction and Reversal of Nitroglycerin Tolerance in Human Coronary Arteries
May, D. C., Popma, J. J., Black, W. H., Schaefer, S., Lee, H. R., Levine, B. D., & Hillis, L. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171305 · Cited by 166
Elkayam, U. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-667 · Cited by 156
DOUSSIÈRE, J., & VIGNAIS, P. V. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17159.x · Cited by 153
Axelsson, K. L., & Andersson, R. G. G. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90393-x · Cited by 148
Molina, C. R., Andresen, J. W., Rapoport, R. M., Waldman, S. A., & Murad, F. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710000-00001 · Cited by 128
RAGAN, C. I., & Bloxham, D. P. (1977) · Biochemical Journal · doi:10.1042/bj1630605 · Cited by 115
Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation
Cherry, P. D., Omar, H. Α., Farrell, K. A., Stuart, J. S., & Wolin, M. S. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.4.h1056 · Cited by 112
Mülsch, A., Busse, R., & Bassenge, E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90066-0 · Cited by 62
A Reappraisal of Nitrate Therapy
Abrams, J. (1988) · JAMA · doi:10.1001/jama.1988.03720030056035 · Cited by 61
Cross, A. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90356-x · Cited by 58
Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure
Packer, M., Lee, W. S., KESSLER, P., Gottlieb, S. S., Medina, N., & Yushak, M. (1988) · Survey of Anesthesiology · doi:10.1097/00132586-198804000-00016 · Cited by 21
Cited by
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Self-citationPLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Nitric oxide donors: chemical activities and biological applications
Wang, P. G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., & Janczuk, A. J. (2002) · Chemical Reviews · doi:10.1021/cr000040l · Cited by 1,337
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Metadata
- Authors
- Münzel, T., Sayegh, H., Freeman, B. A., Tarpey, M. M., & Harrison, D. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 187-194
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2081394289
- Cited by
- 655
- References
- 30
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.